Objectives To examine the prognostic value of preoperative alfa-fetoprotein (AFP) density
and other clinical factors in patients undergoing percutaneous radiofrequency ablation …

Objective This study aimed to investigate the role of the alpha fetoprotein (AFP) ratio before
and after radiofrequency ablation (RFA) in the prognosis of patients with liver cancer …

AIMS: To evaluate the clinical inference of serum alpha-fetoprotein (AFP) response in
hepatocellular carcinoma (HCC) patients undergoing percutaneous radiofrequency ablation …

Background: Prognostic nutritional index (PNI) that was designed to assess the nutritional
and immunological status of patients and albumin–bilirubin (ALBI) grades can be used as …

Aim Recurrence of hepatocellular carcinoma (HCC) is observed frequently, even after
curative treatments. The aim of this study is to elucidate the risk factors for recurrence of …

Preoperative prediction of tumor recurrence after radiofrequency ablation (RFA) in patients
with early hepatocellular carcinoma (HCC) is helpful for clinical decision-making before …

Purpose The aim of this study was to develop prognostic scores, including the tumor burden
score (TBS) and albumin-bilirubin (ALBI) grade, for evaluating the outcomes of …

Abstract Background and Aim: To assess the significance of adequate α‐fetoprotein
decrease in monitoring the treatment effects of radiofrequency ablation (RFA) in …

Background Many methods are used to treat liver cancer. Among them, radiofrequency
ablation (RFA) is a hot topic because of its advantages. This study was designed to …

Objective To determine the survival outcome and prognostic factors of hepatocellular
carcinoma (HCC) survival in patients who underwent radiofrequency ablation (RFA) …